Jon T. Gertken, MD
https://reachmd.com/profiles/jon-t-gertken-md/jmQw32/
Dr. JT Gertken is a specialist in Physical Medicine and Rehabilitation and medical director of therapies and long term acute care for Mosaic Life Care in St. Joseph, Missouri. His practice has been built on providing comprehensive musculoskeletal, spine and general rehabilitative care and aims to h…
Recapping a Narrative Review on the Management of Chronic Kidney Disease in T2D
https://reachmd.com/programs/diabetes-discourse/recapping-a-narrative-review-on-the-management-of-kidney-disease-in-t2d/15884/
How can we best manage kidney disease in patients with type 2 diabetes? Find out with this recap of a recent narrative review.
Overcoming Clinical Inertia in Hyperkalemia Management
https://reachmd.com/programs/cme/overcoming-clinical-inertia-in-hyperkalemia-management/15321/
Improve CKD patient care by mastering hyperkalemia management & RAASi use. Overcome clinical inertia and build a collaborative approach to care.
Statin Safety Considerations
https://reachmd.com/programs/lipid-luminations/statin-safety-considerations/6606/
Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin
Gastroparesis: Causes and Management Strategies
https://reachmd.com/programs/gi-insights/gastroparesis-causes-and-management-strategies/4722/
How does delayed gastric emptying, or gastroparesis, affect patients? What are some of the common comorbid conditions of gastroparesis, and why are women and diabetic patients more susceptible? Dr. Linda Lee, clinical director of the division of gastroenterology and hepatology and director of the Jo
New Kind of Blindness Found: LVPEI Researchers
https://reachmd.com/news/new-kind-of-blindness-found-lvpei-researchers/2451453/
New kind of blindness found: LVPEI researchers Diseases due to the present-day lifestyle are re…
Combination Treatment Beneficial in Albuminuric CKD
https://reachmd.com/news/combination-treatment-beneficial-in-albuminuric-ckd/2449526/
TUESDAY, Nov. 29, 2022 (HealthDay News) — For patients with albuminuric chronic kidney disease (CKD) without diabetes, treatment with the combination of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and sodium-glucose cotransporter-2 (SGLT2) inhibitors increases kidney fail…
FDA approves SGLT2i for reduction of HF hospitalization in T2DM with high CV risk
https://reachmd.com/news/fda-approves-sglt2i-for-reduction-of-hf-hospitalization-in-t2dm-with-high-cv-risk/2455563/
News - Oct. 22, 2019The US Food and Drug Administration (FDA) has approved dapagliflozin for the reduction of heart failure hospitalization in T2DM patients with established CVD or multiple CV risk factors, based on the results from the DECLARE-TIMI 58 trial.Dr. Stephen Wiviott of Brigham and Women…
Harold Bays, MD, FNLA
https://reachmd.com/profiles/harold-bays-md-fnla/jQev9Z/
Harold Bays, MD. FNLA, is Board Certified in Endocrinology and Internal Medicine. Dr. Bays has served as an Investigator for over 400 Phase I - IV clinical trials regarding treatments for dyslipidemias, obesity, diabetes mellitus, hypertension, and other metabolic and hormonal disorders. As Medical…
David Eichenbaum, MD
https://reachmd.com/profiles/david-eichenbaum-md/jVQBYq/
Dr. Eichenbaum is a board certified ophthalmologist fellowship-trained in diseases and surgery of the vitreous and retina. He has been practicing in Tampa Bay since 2007 and was born in St. Petersburg. He completed the Medical Honors Program completing his undergraduate and medical degree at the Un…